Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations

ER Pearson; I Flechtner; PR Njolstad; MT Malecki; SE Flanagan; B Larkin; FM Ashcroft; I Klimes; E Codner; V Iotova; AS Slingerland; J Shield; JJ Robert; JJ Holst; Penelope Clark; S Ellard; O Sovik; M Polak; AT Hattersley

doi:10.1056/NEJMoa061759

Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations

ER Pearson
, I Flechtner
, PR Njolstad
, MT Malecki
, SE Flanagan
, B Larkin
, FM Ashcroft
, I Klimes
, E Codner
, V Iotova
, AS Slingerland
, J Shield
, JJ Robert
, JJ Holst
, Penelope Clark
, S Ellard
, O Sovik
, M Polak
, AT Hattersley

Birmingham Medical School

Research output: Contribution to journal › Article

720 Citations (Scopus)

Original language	English
Pages (from-to)	467-477
Number of pages	11
Journal	New England Journal of Medicine
Volume	355
Issue number	5
DOIs	https://doi.org/10.1056/NEJMoa061759
Publication status	Published - 3 Aug 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1056/NEJMoa061759

Cite this

Pearson, ER., Flechtner, I., Njolstad, PR., Malecki, MT., Flanagan, SE., Larkin, B., Ashcroft, FM., Klimes, I., Codner, E., Iotova, V., Slingerland, AS., Shield, J., Robert, JJ., Holst, JJ., Clark, P., Ellard, S., Sovik, O., Polak, M., & Hattersley, AT. (2006). Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. New England Journal of Medicine, 355(5), 467-477. https://doi.org/10.1056/NEJMoa061759

@article{fff90c783c2640e1aba3cb712d9db37e,

title = "Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations",

author = "ER Pearson and I Flechtner and PR Njolstad and MT Malecki and SE Flanagan and B Larkin and FM Ashcroft and I Klimes and E Codner and V Iotova and AS Slingerland and J Shield and JJ Robert and JJ Holst and Penelope Clark and S Ellard and O Sovik and M Polak and AT Hattersley",

year = "2006",

month = aug,

day = "3",

doi = "10.1056/NEJMoa061759",

language = "English",

volume = "355",

pages = "467--477",

journal = "New England Journal of Medicine",

issn = "1533-4406",

publisher = "Massachusetts Medical Society",

number = "5",

}

Pearson, ER, Flechtner, I, Njolstad, PR, Malecki, MT, Flanagan, SE, Larkin, B, Ashcroft, FM, Klimes, I, Codner, E, Iotova, V, Slingerland, AS, Shield, J, Robert, JJ, Holst, JJ, Clark, P, Ellard, S, Sovik, O, Polak, M & Hattersley, AT 2006, 'Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations', New England Journal of Medicine, vol. 355, no. 5, pp. 467-477. https://doi.org/10.1056/NEJMoa061759

TY - JOUR

T1 - Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations

AU - Pearson, ER

AU - Flechtner, I

AU - Njolstad, PR

AU - Malecki, MT

AU - Flanagan, SE

AU - Larkin, B

AU - Ashcroft, FM

AU - Klimes, I

AU - Codner, E

AU - Iotova, V

AU - Slingerland, AS

AU - Shield, J

AU - Robert, JJ

AU - Holst, JJ

AU - Clark, Penelope

AU - Ellard, S

AU - Sovik, O

AU - Polak, M

AU - Hattersley, AT

PY - 2006/8/3

Y1 - 2006/8/3

U2 - 10.1056/NEJMoa061759

DO - 10.1056/NEJMoa061759

M3 - Article

C2 - 16885550

SN - 1533-4406

VL - 355

SP - 467

EP - 477

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 5

ER -